%0 Journal Article
%T Valvulopathies and Genetics: Where are We?
%A Coll M
%A Fernández-Falgueras A
%A Iglesias A
%A Brugada R
%J Rev Cardiovasc Med
%V 25
%N 2
%D 2024 Feb
%M 39077344
%F 4.43
%R 10.31083/j.rcm2502040
%X Valvulopathies are among the most common cardiovascular diseases, significantly increasing morbidity and mortality. While many valvular heart diseases are acquired later in life, an important genetic component has been described, particularly in mitral valve prolapse and bicuspid aortic valve. These conditions can arise secondary to genetic syndromes such as Marfan disease (associated with mitral valve prolapse) or Turner syndrome (linked to the bicuspid aortic valve) or may manifest in a non-syndromic form. When cardiac valve disease is the primary cause, it can appear in a familial clustering or sporadically, with a clear genetic component. The identification of new genes, regulatory elements, post-transcriptional modifications, and molecular pathways is crucial to identify at-risk familial carriers and for developing novel therapeutic strategies. In the present review we will discuss the numerous genetic contributors of heart valve diseases.